Market Research Reports, Inc.

Cardiac Rhythm Management Devices Market in China to Grow at a CAGR of 10.1% During the Period 2016 - 2020; Finds New Report

Market Research Reports, Inc. has announced the addition of “Cardiac Rhythm Management Devices Market in China 2016 - 2020” research report to their website


Lewes, DE -- (SBWIRE) -- 06/30/2016 -- Report forecast the cardiac rhythm management devices market in China to grow at a CAGR of 10.1% during the period 2016-2020.

Cardiac rhythm management or electrophysiology therapy helps diagnose and treat heart disorders that cause rhythm complications. These disorders include bradycardia and tachycardia that affect the heart's electrical system. These disorders cause irritation in the heart muscles, causing abnormal heart functions. This can occur during heart attacks. Devices such as ICDs, CRT systems, and biventricular pacemakers help manage these disorders.

The report covers the present scenario and the growth prospects of the cardiac rhythm management devices market in China 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of pacemakers, ICTs, and CRT devices.

According to the report, one driver fostering the prospects for growth in this market will be the increase in joint ventures. Strict product approval processes and safety regulations with regard to medical devices make it hard for international vendors to enter the market in China. The country is frequently amending its regulations to provide a safe and better healthcare system. China is also encouraging local manufacturers to develop advanced medical devices.

Further, the report states that the preference for open surgeries will impede market growth until the end of the forecast period. Minimally invasive procedures help prevent excessive blood loss, cause minimal pain and scarring, reduce the duration of recovery and hospital stay, and lead to better medical outcomes. However, these procedures are limited to Tier I and some of Tier II medical facilities such as hospitals and clinics in China. Tier III hospitals cater to rural areas. These hospitals do not have advanced facilities and experienced surgeons to conduct sophisticated minimally invasive procedures for cardiac rhythm management. As a result, people in these hospitals undergo open surgeries for cardiac rhythm management.

Cardiac Rhythm Management Devices Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the cardiac rhythm management devices market in China: BIOTRONIK, Boston Scientific, LivaNova, and Medtronic.

Other Prominent Vendors in the market are: Anjue Medical Equipment, Beijing Carejoy Technology, Cardiac Science (a subsidiary of Opto Circuits), CardiAid, E&M Electromedicina, EMTEL, Fukuda Denshi, Guangzhou Leyte Electronic, Guangzhou Maya Medical Equipment, Guangzhou Yueshan Medical Equipment, Hagenuk, Instramed, Lepu Medical Technology (Beijing), Mindray Medical International, Perlong Medical Equipment, Physio Control, Poweam Medical, and Wincom.

Market driver
- Prevalence of cardiac disorders
- For a full, detailed list, view our report

Market challenge
- Promotion of locally manufactured products
- For a full, detailed list, view our report

Market trend
- Popularity of robot-assisted cardiac surgery
- For a full, detailed list, view our report

Key questions answered in this report

- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 66 pages and 33 Exhibit "Cardiac Rhythm Management Devices Market in China 2016 - 2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Healthcare reform in China, Regulatory landscape, Insurance coverage and reimbursement in China, Opportunities for global and local vendors, Market segmentation by product, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at:

Related Reports;

Global DNA Sequencing Products Market 2016-2020 - Visit at -

rhEPO Market in China 2016-2020 - Visit at -

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: